Company Overview of Shanghai Fosun High Technology (Group) Co., Ltd.
Shanghai Fosun High Technology (Group) Co., Ltd., through its subsidiaries, engages in insurance, industrial operations, investments, and asset management businesses. The company provides life and health, property and casualty, and personal insurance products, as well as reinsurance services; and engages in pharmaceutical manufacturing, pharmaceutical distribution and retail, healthcare services, and diagnostic products and medical devices businesses. It also specializes in property development projects in Shanghai, Beijing, Tianjin, Nanjing, Chongqing, Chengdu, Xi'an, Wuhan, Datong, Wuxi, Hangzhou, Taiyuan, Changsha, Changchun, etc.; mining, coking, sintering, iron smelting, steel smelting,...
No. 2 East Fuxing Road
Founded in 1992
Key Executives for Shanghai Fosun High Technology (Group) Co., Ltd.
Co-Founder and Non-Executive Director
Compensation as of Fiscal Year 2014.
Shanghai Fosun High Technology (Group) Co., Ltd. Key Developments
Alimentation Couche-Tard, Tencent Holdings, China Life Insurance, ENN Energy Holdings, Fosun Group, Hopu Investment Management and Affinity Equity Partners Eyeing Sinopec
Aug 19 14
Alimentation Couche-Tard Inc. (TSX:ATD.B), Tencent Holdings Ltd. (SEHK:700) (Tencent), China Life Insurance Co. Ltd. (SEHK:2628) (China Life), ENN Energy Holdings Limited (SEHK:2688) (ENN), Shanghai Fosun High Technology (Group) Co. Ltd. (Fosun), Hopu Jinghua (Beijing) Investment Consultancy Co., Ltd and Affinity Equity Partners (Affinity) have been shortlisted to acquire China Petroleum & Chemical Corp. (SEHK:386) (Sinopec), Reuters reported citing people familiar with the matter. Sinopecplans to sell up to 30 percent of Sinopec Sales by end-2014. Final bids are due by end-August 2014. China International Capital Corp, Deutsche Bank (DBKGn.DE), CITIC Securities Ltd (600030.SS) and Bank of America (BAC.N) are advising Sinopec. Sinopec, ENN, Affinity, Tencent, China Life and Fosun all declined to comment about the bidding process. Couche-Tard Chief Executive Officer Raymond Paré also declined to comment. Hopu could not be reached for an immediate comment.
Sinopharm Group Co. Ltd. and Shanghai Fosun High Technology (Group) Co., Ltd. Declare Cooperation Form JV to Build Nationwide Drug Logistics Network
Jun 7 14
Sinopharm Group Co. Ltd. and Shanghai Fosun High Technology (Group) Co., Ltd. declared cooperation to form a JV, which will build nationwide drug logistics network. The first drug logistics project will be built in Hangzhou City, Zhejiang Province, east China, developing into a provincial drug logistics center. Early stage investment will reach USD 500 million to USD 1 billion. The JV will be 60% to 40% held by Shanghai Fosun and Sinopharm Group. Both sides planned to build up ten regional logistics centers, 20 provincial logistics centers and 30 provincial delivery centers within three to five years, with storage area reaching 300 hectares.
Fosun Interested In Healthscope
May 12 14
Shanghai Fosun High Technology (Group) Co., Ltd. is interested in acquiring Healthscope Limited, the Australian Financial Review reported. Patrick Zhong, Head of Global Investments at Fosun, told Australian Financial Review that the company saw a great opportunity for Healthscope to develop in China. Zhong said, "Healthscope is a pretty large company, but think about if they had the same position in China (as in Australia). The counterpart of Healthscope would be huge - 10 times larger potentially. This is the opportunity."
Similar Private Companies By Industry
Recent Private Companies Transactions